Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.
AffiliationCR-UK Stromal-Tumour Interaction Group, Paterson Institute for Cancer Research, The University of Manchester, Wilmslow Road, Manchester M20 4BX, UK.
MetadataShow full item record
AbstractCancerous stroma coevolves alongside tumour progression, thereby promoting the malignant conversion of epithelial carcinoma cells. To date, an abundance of data have supported crucial roles of the tumour microenvironment (TME) in providing cancer cells with proliferative, migratory, survival and invasive propensities favouring the processes of tumourigenesis. The cancerous reactive stroma is frequently populated by a large number of myofibroblasts (MFs), which are activated, non-transformed fibroblasts expressing α-smooth muscle actin (α-SMA). MFs together with non-MF cells present in the tumour-associated stroma are collectively referred to as carcinoma-associated fibroblasts (CAFs), one of the major stromal cell types recognised in various human carcinomas. Recruitment of fibroblasts and/or their progenitors to a tumour mass and their subsequent transdifferentiation into MFs, as well as ongoing maintenance of their activated state, are believed to be essential processes facilitating tumour progression. However, the complex networks of signalling pathways mediating the phenotypic conversion into CAFs, as well as those underlying their tumour-promoting interactions with other tumour-constituting cells, have yet to be fully explored. Histopathological confirmation of the presence of large numbers of CAF MFs within TME and their altered gene expression profiles are known to be associated with disease progression and to serve as independent negative prognostic factors for a wide range of tumour types. In this review, we examine the current evidence shedding light on the emerging roles of tumour-promoting CAFs, cells that are pivotal for epithelial cancer development and progression, and discuss the therapeutic potential of targeting these cells. J. Cell. Physiol. © 2013 Wiley Periodicals, Inc.
CitationCarcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. 2013: J Cell Physiol
JournalJournal of Cellular Physiology
- Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts.
- Authors: Polanska UM, Acar A, Orimo A
- Issue date: 2011 Oct 25
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.
- Authors: Shimoda M, Mellody KT, Orimo A
- Issue date: 2010 Feb
- GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
- Authors: Peng Y, Li Z, Li Z
- Issue date: 2013 Nov 1
- Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.
- Authors: Lebret SC, Newgreen DF, Thompson EW, Ackland ML
- Issue date: 2007
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
- Authors: Cirri P, Chiarugi P
- Issue date: 2012 Jun